Elimination of graft versus host disease in matched allogeneic leukemic transplant recipients using CAMPATH-1.

Eitemau Tebyg

• Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1).
  gan: Waldmann, H, et al.
  Cyhoeddwyd: (1984)
• ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA USING CAMPATH-1 MONOCLONAL-ANTIBODIES AND POSTTRANSPLANT ALLOIMMUNIZATION WITH DONOR LYMPHOCYTES
  gan: Naparstek, E, et al.
  Cyhoeddwyd: (1993)
• Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders.
  gan: Slavin, S, et al.
  Cyhoeddwyd: (1987)
• PREVENTION OF GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA BY T-CELL DEPLETION INVITRO PRIOR TO TRANSPLANTATION
  gan: Slavin, S, et al.
  Cyhoeddwyd: (1985)
• Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies.
  gan: Naparstek, E, et al.
  Cyhoeddwyd: (1999)